LONDON, March 2 (Reuters) - Haleon, the world's biggest standalone consumer health business, on Thursday forecast 4-6% organic revenue growth in 2023. (Reporting by Natalie Grover and Maggie Fick in London Editing by David Goodman )
![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:
Read more